CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 10.63: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.39%
Annual Rate
CNY 0.30Paid unknown
Payout Ratio
63.9%Moderate
Payback Period
30.2 yr
Last Ex-Dividend
Jun 16, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.55BCNY678.52M · vs all stocks (USD)
Trailing P/E
19.23xRevenue (TTM)
1.01BCNY150.07M · vs all stocks (USD)
Profit Margin
23.47%Beta
0.4020xvs all stocks
52-Week Change
40.37%vs all stocks
Forward Annual Dividend Yield
3.39%vs all stocks
Market Capitalization
4.55BCNY678.52M · vs all stocks (USD)
Enterprise Value
4.11BCNY612.73M · vs all stocks (USD)
Trailing P/E
19.23xPrice to Sales (TTM)
4.52xPrice to Book (MRQ)
1.94xEnterprise to Revenue
4.08xEnterprise to EBITDA
17.04xGross Margin
77.23%Profit Margin
23.47%Operating Margin
20.42%Return on Assets (TTM)
5.00%Return on Equity (TTM)
10.28%Revenue (TTM)
1.01BCNY150.07M · vs all stocks (USD)
Revenue per Share (TTM)
2.00CNYUpdated Sep 19, 2026Quarterly Revenue Growth
-11.10%Gross Profit (TTM)
780.52MCNY116.42M · vs all stocks (USD)
EBITDA (TTM)
334.98MCNY49.97M · vs all stocks (USD)
Net Income (TTM)
236.17MCNY35.23M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
19.00%Operating Cash Flow (TTM)
188.91MCNY28.18M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
44.67MCNY6.66M · vs all stocks (USD)
Forward Annual Dividend Rate
0.3000CNYUpdated Sep 19, 2026Forward Annual Dividend Yield
3.39%vs all stocks
Trailing Annual Dividend Rate
0.3000CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
3.39%vs all stocks
Payout Ratio
63.92%Revenue
1.04BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
235.14MCNYFY2025 · Dec 31, 2025Gross Profit
803.62MCNYFY2025 · Dec 31, 2025Operating Income
241.86MCNY36.08M · vs all stocks (USD)
Pre-tax Income
238.61MCNYFY2025 · Dec 31, 2025Income Tax Expense
40.49MCNYFY2025 · Dec 31, 2025Net Income
198.12MCNYFY2025 · Dec 31, 2025EBIT
240.27MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
289.34MCNYFY2025 · Dec 31, 2025Research & Development
39.04MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
315.87MCNYFY2025 · Dec 31, 2025Other Operating Expenses
26.44MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.23MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3937CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3937CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
503.23MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
503.23MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
198.12MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
207.05MCNYFY2025 · Dec 31, 2025Free Cash Flow
195.97MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
169.65MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
198.12MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.47MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.37MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.83MCNYFY2025 · Dec 31, 2025Capital Expenditures
-11.08MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.30BCNYFY2025 · Dec 31, 2025Sale of Investments
1.21BCNYFY2025 · Dec 31, 2025Other Investing Activity
-79.78MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-173.61MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
56.06MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-83.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.73MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-28.67MCNYFY2025 · Dec 31, 2025Shares Outstanding
503.20MSharesUpdated Sep 19, 2026Float Shares
249.43MSharesUpdated Sep 19, 2026% Held by Insiders
54.04%vs all stocks
% Held by Institutions
0.81%vs all stocks
Total Cash (MRQ)
442.07MCNY65.94M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.8790CNYUpdated Sep 19, 2026Total Debt (MRQ)
998.12KCNY148.88K · vs all stocks (USD)
Current Ratio (MRQ)
14.79xBook Value per Share (MRQ)
4.65CNYUpdated Sep 19, 2026Total Assets
2.69BCNY401.70M · vs all stocks (USD)
Total Current Assets
1.32BCNYFY2025 · Dec 31, 2025Total Liabilities
312.15MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.37BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
23.82MCNYFY2025 · Dec 31, 2025Total Current Liabilities
288.33MCNYFY2025 · Dec 31, 2025Cash
169.65MCNYFY2025 · Dec 31, 2025Cash Equivalents
80.00MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
249.65MCNYFY2025 · Dec 31, 2025Other Short-term Investments
333.80MCNYFY2025 · Dec 31, 2025Accounts Receivable
282.22MCNYFY2025 · Dec 31, 2025Inventory
208.44MCNYFY2025 · Dec 31, 2025Accounts Payable
34.28MCNYFY2025 · Dec 31, 2025Short-term Debt
57.50MCNYFY2025 · Dec 31, 2025Other Current Liabilities
15.25MCNYFY2025 · Dec 31, 2025Common Stock (Book)
503.20MCNYFY2025 · Dec 31, 2025Retained Earnings
1.43BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.38BCNY355.14M · vs all stocks (USD)
52-Week Low
5.32CNYUpdated Sep 19, 202652-Week High
14.23CNYUpdated Sep 19, 202652-Week Change
40.37%vs all stocks
Beta
0.4020xvs all stocks
50-Day MA
8.40CNYUpdated Sep 19, 2026200-Day MA
7.15CNYUpdated Sep 19, 2026Avg 10-Day Volume
51.22MSharesUpdated Sep 19, 2026Avg 30-Day Volume
62.83MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
0.4700CNYUpdated Sep 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.63: safe zoneNotable
Altman Z-Score: 10.63
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Sinotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou AGS Medtech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MiMedx Group, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ironwood Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seers Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Fuan Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zevra Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Gen Ilac ve Saglik Urunleri A.S.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Fangsheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Avanti Feeds Ltd.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income Growth
Ies Holdings Inc.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income Growth
Suzhou Sepax Technologies Inc.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income Growth